Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Zutphen, The Netherlands - 31 December 2016 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announced during the year 2016 that it prepares a significant external funding to which the...
-
ESPERITE N.V.: Stem Cells, Genetic Tests and Pharmaceuticals Patent granted to Cell Factory in Europe confirms...
-
Esperite N.V. (ESP) expands extracellular vesicles (exosomes) products portfolio to include inflammatory bowel disease. The Cell Factory develops therapy for Crohn's disease. Esperite's business...
-
Esperite (ESP) leads international consortium for clinical translation of extracellular vesicles use in various therapies Extracellular vesicles...
-
ESPERITE N.V. (ESP) announces additional information on envisaged financing Zutphen, The Netherlands - 29 August 2016...
-
ESPERITE N.V. (ESP) publishes revenue increase of 6% compared to HY1 2015 and 8% compared to HY2 2015 Significant...
-
ESPERITE N.V. announces important recurrent financial improvements from Laboratory transfer and cost reduction program Galaxy 1.2 Millions euro saving per...
-
ESPERITE N.V. is confident in its future and successes Esperite comments on FD article Zutphen, The Netherlands - 31 January 2016 On 30...
-
ESPERITE N.V. is confident in its future and successes Esperite comments on FD article Zutphen, The Netherlands - 31 January...
-
ESPERITE (ESP) Trading update Q1-2016 Genoma grows and widens its footprint on the market. CryoSave newly configured, launches new products for Q2 2016.Effectiveness of cost...